Evidence map›Paper›PMID 24879067›Full record

ArticleStem cell research2014

Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics.

Mariella Mannino, Natividad Gomez-Roman, Helfrid Hochegger, Anthony J Chalmers

Open access · goldAbstract read
In one paragraph

Article in Stem cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Cellular senescence in glioma.Journal of neuro-oncology · 2023
    Review
  3. Article
  4. High Expression ofGenes · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.International journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mariella ManninoGenome Damage and Stability Centre, University of Sussex, Brighton BN19RQ, UK.
Natividad Gomez-RomanInstitute of Cancer Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Helfrid HocheggerGenome Damage and Stability Centre, University of Sussex, Brighton BN19RQ, UK. Electronic address: h.hochegger@sussex.ac.uk.
Anthony J ChalmersInstitute of Cancer Sciences, University of Glasgow, Glasgow G12 8QQ, UK. Electronic address: anthony.chalmers@glasgow.ac.uk.
University of Glasgow · GBUniversity of Sussex · GB

Funding

Cancer Research UK C28206/A14499Medical Research Council G0802755
6 · The paper itself

Abstract

Glioma stem-cell-like cells are considered to be responsible for treatment resistance and tumour recurrence following chemo-radiation in glioblastoma patients, but specific targets by which to kill the cancer stem cell population remain elusive. A characteristic feature of stem cells is their ability to undergo both symmetric and asymmetric cell divisions. In this study we have analysed specific features of glioma stem cell mitosis. We found that glioma stem cells appear to be highly prone to undergo aberrant cell division and polyploidization. Moreover, we discovered a pronounced change in the dynamic of mitotic centrosome maturation in these cells. Accordingly, glioma stem cell survival appeared to be strongly dependent on Aurora A activity. Unlike differentiated cells, glioma stem cells responded to moderate Aurora A inhibition with spindle defects, polyploidization and a dramatic increase in cellular senescence, and were selectively sensitive to Aurora A and Plk1 inhibitor treatment. Our study proposes inhibition of centrosomal kinases as a novel strategy to selectively target glioma stem cells.

Indexed as

AnimalsAurora Kinase AAzepinesBrain NeoplasmsCell Line, TumorCentrosomeGlioblastomaHeLa CellsHumansMiceMitosisNeoplastic Stem CellsPolyploidyProtein Kinase InhibitorsPyrimidinesXenograft Model Antitumor AssaysAurora Kinase AAzepinesMLN 8237Protein Kinase InhibitorsPyrimidines

Identifiers

PMID24879067
PMCPMC4085484
OpenAlexW1971896486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.